Viewing nowCombinationTwinstar Tablets 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.

MFDS item code 201005082 · Approved 2010.08.19 · Insurance code 653501290
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with either amlodipine or telmisartan. It helps effectively lower blood pressure by using both medications together and reduces the risk of complications from hypertension. This medication is a good choice when blood pressure control is inadequate.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended that the doses of the individual components (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients requiring careful administration'). For elderly patients 75 years of age or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication may pose serious risks to the fetus during pregnancy, especially in the second and third trimesters. Therefore, it should be discontinued immediately if pregnancy is confirmed. This medication should not be administered to patients with certain diseases, such as liver disorders, heart disease, hypotension, renal impairment, and women who are pregnant or breastfeeding. Patients with primary aldosteronism, certain heart valve diseases, liver impairment, gastrointestinal diseases, renal artery hypertension, dialysis patients, and the elderly should take extra caution when using this medication. Common side effects of this medication include dizziness and peripheral edema, but severe adverse reactions may occur rarely, so if any abnormal symptoms arise, immediate consultation with healthcare professionals is necessary. Use during pregnancy may harm the fetus, so alternative safe treatment options should be considered if planning to conceive or if currently pregnant, and it should be avoided during breastfeeding. This medication may affect renal function; therefore, patients with renal impairment should undergo regular blood tests to monitor their condition. There may be symptoms of hypotension with excessively low blood pressure; hence, especially in cases of dehydration or in patients taking diuretics, consultation with a physician before taking the medication is necessary, and appropriate measures should be taken if symptoms occur. This medication may interact with other drugs, so patients should inform healthcare professionals of any other medications they are taking, particularly caution is needed when combined with lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. Dizziness or drowsiness may occur while driving or operating machinery, so caution is advised. In cases of overdose, severe hypotension, dizziness, and cardiac anomalies may occur, necessitating immediate medical treatment. This medication is not recommended for children as safety and efficacy have not been established, and for the elderly, dose adjustment and careful observation are required. When storing, keep out of reach of children, maintain the product in its original packaging, and it is advisable to open the package just before consumption.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light; therefore, it should be stored in a tightly sealed container that prevents light exposure. Additionally, it is best to store the medication at room temperature between 1°C and 30°C. By storing it this way, the effectiveness of the medication can be maintained for a longer time.
A white and light blue, double convex, oval-shaped dual tablet.
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.